HOME >> BIOLOGY >> NEWS
When it counts: Shortening imaging time for individuals with suspected heart problems

SAN DIEGO, Calif.--Researchers discovered that the time spent on a myocardial perfusion single photon emission computed tomography (SPECT) imaging study--also called a cardiac stress/rest test--can be cut in half using a trademarked, innovative reconstruction technology. These results--from researchers at Cardiac Imaging of Augusta and the Medical College of Georgia--were presented at SNM's 53rd Annual Meeting June 37 in San Diego.

"Using UltraSPECT's Wide Beam Reconstruction (WBR)TM can reduce imaging time by 50 percent and improve image quality--without introducing artifacts (distortions) or deleting useful information," said Danny Basso, a certified nuclear medicine technologist and manager with Cardiac Imaging of Augusta. "This allows for increased patient comfort, less patient motion and increased throughput (rate of receiving data) for the nuclear medicine department," added the co-author of "A Clinical Evaluation of a Wide Beam Reconstruction Method for Shortening Scan Time of Gated Cardiac Rest/Stress SPECT." WBR is an algorithm "that uses modeling to reduce the bad counts and increase the good counts by placing the counts where they are suppose to be," explained Basso. "This same technology can be used to improve other molecular imaging/nuclear medicine procedures as well," he added.

A myocardial perfusion SPECT imaging study--also called a cardiac stress/rest test--helps evaluate a patient's heart's blood supply. About 7.5 million individuals--or 1 in every 40 Americans--undergo these cardiac scans every year. A radiotracer, a compound containing both a radioactive isotope and a pharmaceutical agent, is injected into a patient's vein. The radioactive isotope releases energy, and a technologist uses a special gamma camera to acquire multiple images from numerous angles of that energy. A computer can be used to apply a tomographic (sectional) reconstruction algorithm to the multiple projections, yielding 3-D information. Physi
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
5-Jun-2006


Page: 1 2

Related biology news :

1. Every moment counts: Predicting treatment responses earlier for brain tumor patients
2. Shortening chromosomes cause for earlier cancer onset in families with rare syndrome
3. New imaging method clarifies nutrient cycle
4. Methodist, University of Houston, Cornell combine biomedical imaging expertise
5. 2007 Image of the Year: Molecular imaging relates human brain chemistry to aggressive behavior
6. SNM advances professional definition for molecular imaging
7. Combining molecular imaging technologies to stop/prevent heart attacks
8. A first: Simultaneous PET/MR images of the brain debut, increase molecular imaging capabilities
9. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately
10. Decoding gene expression in cancer tumors using noninvasive imaging
11. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy

Post Your Comments:
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... nucleosomes in the cell nucleus makes it unavailable ... in Munich now describes a mechanism that allows ... for transcription. , In higher organisms the genomic ... around disk-shaped particles called nucleosomes, each consisting of ... accommodating two loops of DNA. Packed in this ...
(Date:5/23/2013)... are billions of animal and plant specimens from birds, ... stacked, stored and preserved in jars and collection drawers. ... to understanding how the Earth,s biodiversity is changing in ... only the information were easily accessible. , A new ... a team from the University of Colorado Boulder, is ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Biochemistry: Unspooling DNA from nucleosomal disks 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
(Date:5/23/2013)... 23, 2013 The maker community is ... of inventions. They focus on learning practical skills while ... gravitate toward bringing their ideas to life via crowdfunding. ... works on making projects using biology. Glowing Plant has ... to make them glow with bioluminescence genes, and has ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics ... company developing DCVax ® personalized immune therapies for ... its exhibit at this year,s American Society Of Clinical ... to highlight its leadership role in immune therapy.  ... ASCO annual meeting is the pre-eminent conference focused on ...
(Date:5/23/2013)... 2013 During the conduct of ... adhere to principles of good clinical practice (GCP) ... Dr. Jeremy Lim, Fellow, Clinical Development at Novartis ... ,     Understand the International Conference on Harmonization (ICH) ... regulations for the conduction of clinical trials , ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
Cached News: